This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nanjing Ruijie Pharmatech Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations of Hong Liao in Pharmaceutical Development
Introduction
Hong Liao is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as therapeutic agents. His work focuses on addressing diseases mediated by ACC, showcasing his commitment to advancing medical science.
Latest Patents
Hong Liao holds a patent for "Compounds and their uses as ACC inhibitors." This invention provides compounds of Formula (I) that can be utilized as ACC inhibitors, demonstrating potent therapeutic effects against various diseases. His innovative approach highlights the potential of these compounds in medical applications.
Career Highlights
Hong Liao is associated with Nanjing Ruijie Pharmatech Co., Ltd., where he continues to contribute to pharmaceutical research and development. His expertise in creating effective therapeutic agents has positioned him as a valuable asset in the industry.
Collaborations
Hong Liao has collaborated with notable colleagues, including Junbo Zhang and Peipei Wang. These partnerships enhance the research environment and foster innovation within the company.
Conclusion
Hong Liao's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions through patents and collaborations are paving the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile